Improving patient outcomes in psoriasis: strategies to ensure treatment adherence

References

• BoehnckeWHKatsambasAOrtonneJPPuigLEADV preceptorship: advances in dermatologyJ Eur Acad Dermatol Venereol201024Suppl 5224
   PubMed Web of Science ®Google Scholar
• AliSMBrodellRTBalkrishnanRFeldmanSRPoor adherence to treatments: a fundamental principle of dermatologyArch Dermatol2007143791291517638737
   PubMedGoogle Scholar
• ChapmanBPMoynihanJThe brain-skin connection: role of psychosocial factors and neuropeptides in psoriasisExpert Rev Clin Immunol20095662362720477685
   PubMed Web of Science ®Google Scholar
• AronsonJKCompliance, concordance, adherenceBr J Clin Pharmacol200763438338417378797
   PubMed Web of Science ®Google Scholar
• StormABenfeldtEAndersenSESerupJA prospective study of patient adherence to topical treatments: 95% of patients underdoseJ Am Acad Dermatol200859697598018817998
   PubMed Web of Science ®Google Scholar
• CarrollCLFeldmanSRCamachoFTBalkrishnanRBetter medication adherence results in greater improvement in severity of psoriasisBr J Dermatol2004151489589715491434
   PubMed Web of Science ®Google Scholar
• AtkinsLFallowfieldLIntentional and non-intentional non-adherence to medication amongst breast cancer patientsEur J Cancer200642142271227616644208
   PubMed Web of Science ®Google Scholar
• BewleyABurrageDMErsserSJHansenMWardCIdentifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative studyJ Eur Acad Dermatol Venereol201428676377023663069
   PubMed Web of Science ®Google Scholar
• AndersonKLDothardEHHuangKEFeldmanSRFrequency of primary nonadherence to acne treatmentJAMA Dermatol2015151662362625793290
   PubMed Web of Science ®Google Scholar
• KardasPLewekPMatyjaszczykMDeterminants of patient adherence: a review of systematic reviewsFront Pharmacol201349123898295
   PubMed Web of Science ®Google Scholar
• StormAAndersenSEBenfeldtESerupJOne in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinicJ Am Acad Dermatol2008591273318467003
   PubMed Web of Science ®Google Scholar
• BewleyAPageBMaximizing patient adherence for optimal outcomes in psoriasisJ Eur Acad Dermatol Venereol201125Suppl 491421507078
   PubMed Web of Science ®Google Scholar
• RichardsHLFortuneDGO’SullivanTMMainCJGriffithsCEPatients with psoriasis and their compliance with medicationJ Am Acad Dermatol199941458158310495380
   PubMed Web of Science ®Google Scholar
• FouéréSAdjadjLPawinHHow patients experience psoriasis: results from a European surveyJ Eur Acad Dermatol Venereol200519Suppl 32616274404
   PubMed Web of Science ®Google Scholar
• AugustinMHollandBDartschDLangenbruchARadtkeMAAdherence in the treatment of psoriasis: a systematic reviewDermatology2011222436337421757881
   PubMed Web of Science ®Google Scholar
• RiederETauskFPsoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatmentsInt J Dermatol20125111226
   PubMed Web of Science ®Google Scholar
• RosSPuigLCarrascosaJMCumulative life course impairment: the imprint of psoriasis on the patient’s lifeActas Dermosifiliogr2014105212813423668623
   PubMedGoogle Scholar
• BhattiZUFinlayAYBoltonCEChronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicineJ Eur Acad Dermatol Venereol201428101344135524134436
   PubMed Web of Science ®Google Scholar
• BhattiZUSalekMSFinlayAYMajor life changing decisions and cumulative life course impairmentJ Eur Acad Dermatol Venereol2011252245246 author reply 24621118311
   PubMed Web of Science ®Google Scholar
• HrehorówESalomonJMatusiakLReichASzepietowskiJCPatients with psoriasis feel stigmatizedActa Derm Venereol2012921677221879243
   PubMed Web of Science ®Google Scholar
• RichardsHLFortuneDGGriffithsCEAdherence to treatment in patients with psoriasisJ Eur Acad Dermatol Venereol200620437037916643132
   PubMed Web of Science ®Google Scholar
• FinlayAYKhanGKDermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical useClin Exp Dermatol19941932102168033378
   PubMed Web of Science ®Google Scholar
• ChrenMMLasekRJSahayAPSandsLPMeasurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseasesJ Cutan Med Surg20015210511011443481
   PubMed Web of Science ®Google Scholar
• PathiranaDOrmerodADSaiagPEuropean S3-guidelines on the systemic treatment of psoriasis vulgarisJ Eur Acad Dermatol Venereol200923Suppl 2170
   PubMed Web of Science ®Google Scholar
• MenterAKormanNJElmetsCAGuidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agentsJ Am Acad Dermatol200961345148519493586
   PubMed Web of Science ®Google Scholar
• SamarasekeraESawyerLParnhamJSmithCHGuideline Development GroupAssessment and management of psoriasis: summary of NICE GuidelinesBMJ2012345e671223097521
   PubMed Web of Science ®Google Scholar
• SchmittJMFordDERole of depression in quality of life for patients with psoriasisDermatology20072151172717587835
   PubMed Web of Science ®Google Scholar
• ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
   PubMed Web of Science ®Google Scholar
• GoldbergDBridgesKDuncan-JonesPGraysonDDetecting anxiety and depression in general medical settingsBMJ198829766538978993140969
   PubMed Web of Science ®Google Scholar
• McAleerMAMasonDLCunninghamSAlcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distressBr J Dermatol201116461256126121457207
   PubMed Web of Science ®Google Scholar
• BaborTFHiggins-BiddleJCSaundersJBMonteiroMGAudit: The Alcohol Use Disorders Identification Test Guidelines for Use in Primary Care2nd edGeneva, SwitzerlandWorld Health Organization2001 Available from: http://whqlibdoc.who.int/hq/2001/WHO_MSD_MSB_01.6a.pdfAccessed April 2, 2015
   Google Scholar
• YélamosOPuigLSystemic methotrexate for the treatment of psoriasisExpert Rev Clin Immunol201511555356325779551
   PubMed Web of Science ®Google Scholar
• PoikolainenKKarvonenJPukkalaEExcess mortality related to alcohol and smoking among hospital-treated patients with psoriasisArch Dermatol1999135121490149310606054
   PubMedGoogle Scholar
• JanowskiKPietrzakAIndications for psychological intervention in patients with psoriasisDermatol Ther200821540941118844719
   PubMed Web of Science ®Google Scholar
• ZaghloulSSGoodfieldMJObjective assessment of compliance with psoriasis treatmentArch Dermatol2004140440841415096368
   PubMedGoogle Scholar
• KimballABJacobsonCWeissSVreelandMGWuYThe psychosocial burden of psoriasisAm J Clin Dermatol20056638339216343026
   PubMed Web of Science ®Google Scholar
• FortuneDGRichardsHLKirbyBBowcockSMainCJGriffithsCEA cognitive-behavioural symptom management programme as an adjunct in psoriasis therapyBr J Dermatol2002146345846511952546
   PubMed Web of Science ®Google Scholar
• FordhamBGriffithsCEBundyCCan stress reduction interventions improve psoriasis? A reviewPsychol Health Med201318550151423116223
   PubMed Web of Science ®Google Scholar
• PriceMLMottahedinIMayoPRCan psychotherapy help patients with psoriasis?Clin Exp Dermatol19911621141172032371
   PubMed Web of Science ®Google Scholar
• D’ErmeAMZanieriFCampolmiETherapeutic implications of adding the psychotropic drug escitalopram in the treatment of patients suffering from moderate-severe psoriasis and psychiatric comorbidity: a retrospective studyJ Eur Acad Dermatol Venereol201428224624922963277
   PubMed Web of Science ®Google Scholar
• KossakowskaMMCieścińskaCJaszewskaJPlacekWJControl of negative emotions and its implication for illness perception among psoriasis and vitiligo patientsJ Eur Acad Dermatol Venereol201024442943319744257
   PubMed Web of Science ®Google Scholar
• ErsserSJCowdellFCNichollsPGLatterSMHealyEA pilot randomized controlled trial to examine the feasibility and efficacy of an educational nursing intervention to improve self-management practices in patients with mild-moderate psoriasisJ Eur Acad Dermatol Venereol201226673874521707770
   PubMed Web of Science ®Google Scholar
• FeldmanSRApproaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicleJ Drugs Dermatol20109890891120684140
   PubMed Web of Science ®Google Scholar
• ReichKMrowietzUKarakasiliEZschockeIDevelopment of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)Arch Dermatol Res2014306766767624895177
   PubMed Web of Science ®Google Scholar
• FeldmanSRCamachoFTKrejci-ManwaringJCarrollCLBalkrishnanRAdherence to topical therapy increases around the time of office visitsJ Am Acad Dermatol2007571818317498841
   PubMed Web of Science ®Google Scholar
• DavisSALinHCYuCHBalkrishnanRFeldmanSRUnderuse of early follow-up visits: a missed opportunity to improve patients’ adherenceJ Drugs Dermatol201413783383625007367
   PubMed Web of Science ®Google Scholar
• ErsserSJSurridgeHWilesAWhat criteria do patients use when judging the effectiveness of psoriasis management?J Eval Clin Pract20028436737612421386
   PubMed Web of Science ®Google Scholar
• van CranenburghODde KorteJSprangersMAde RieMASmetsEMSatisfaction with treatment among patients with psoriasis: a web-based survey studyBr J Dermatol2013169239840523565643
   PubMed Web of Science ®Google Scholar
• BakerCSFoleyPABraueAPsoriasis uncovered – measuring burden of disease impact in a survey of Australians with psoriasisAustralias J Dermatol201354Suppl 116
   Google Scholar
• MartinLRWilliamsSLHaskardKBDimatteoMRThe challenge of patient adherenceTher Clin Risk Manag20051318919918360559
   PubMedGoogle Scholar
• WarinoLBalkrishnanRFeldmanSRClobetasol propionate for psoriasis: are ointments really more potent?J Drugs Dermatol20065652753216774104
   PubMedGoogle Scholar
• PuigLRiberaMHernanzJMTreatment of scalp psoriasis: review of the evidence and Delphi consensus of the Psoriasis Group of the Spanish Academy of Dermatology and VenereologyActas Dermosifiliogr201010110827846 Spanish21159259
   PubMedGoogle Scholar
• PappKBerth-JonesJKragballeKWozelGde la BrassinneMScalp psoriasis: a review of current topical treatment optionsJ Eur Acad Dermatol Venereol20072191151116017894698
   PubMed Web of Science ®Google Scholar
• OrtonneJChimentiSLugerTPuigLReidFTrüebRMScalp psoriasis: European consensus on grading and treatment algorithmJ Eur Acad Dermatol Venereol200923121435144419614856
   PubMed Web of Science ®Google Scholar
• LangleyRGSauratJHReichKNail Psoriasis Delphi Expert PanelRecommendations for the treatment of nail psoriasis in patients with moderate to severe psoriasis: a dermatology expert group consensusJ Eur Acad Dermatol Venereol201226337338122151734
   PubMed Web of Science ®Google Scholar
• YélamosOCatalàAVilarrasaERoéEPuigLAcute severe methotrexate toxicity in patients with psoriasis: a case series and discussionDermatology2014229430630925401478
   PubMed Web of Science ®Google Scholar
• PuigLCarrascosaJMBelinchónIPanel de Expertos del Consenso Delphi sobre Tratamiento tópico de la psoriasis; Grupo de Psoriasis de la Academia Española de Dermatología y VenereologíaAdherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and VenereologyActas Dermosifiliogr2013104648849623395400
   PubMedGoogle Scholar
• LebwohlMGBachelezHBarkerJPatient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis SurveyJ Am Acad Dermatol2014705871881e1e3024576585
   PubMed Web of Science ®Google Scholar